Johanne Kaplan - 08 Mar 2023 Form 3 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Chief Development Officer
Signature
/s/ Max Milbury, Attorney-in-Fact for Johanne Kaplan
Issuer symbol
PMN
Transactions as of
08 Mar 2023
Net transactions value
$0
Form type
3
Filing time
16 Mar 2023, 16:28:48 UTC
Next filing
30 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PMN Common Shares 6,317 08 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PMN Option (right to buy) 08 Mar 2023 Common Shares 16,666 $9.00 Direct F1, F2
holding PMN Option (right to buy) 08 Mar 2023 Common Shares 8,333 $10.20 Direct F1, F2
holding PMN Option (right to buy) 08 Mar 2023 Common Shares 16,666 $15.00 Direct F1, F2
holding PMN Option (right to buy) 08 Mar 2023 Common Shares 33,333 $8.40 Direct F1, F3
holding PMN Warrants (right to buy) 08 Mar 2023 Common Shares 4,817 $28.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Conversion or exercise price is in Canadian dollars.
F2 This option is fully vested and exercisable as of the date hereof.
F3 The option agreement provides that the option vests ratably over 48 months following the date of grant (December 9, 2021).

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney